Nanosuspensions in drug delivery

被引：1170
|
作者：
Rabinow, BE [1 ]
机构：
[1] Baxter Healthcare Corp, Strateg Tech Dev, Round Lake, IL 60073 USA
来源：
NATURE REVIEWS DRUG DISCOVERY | 2004年 / 3卷 / 09期
关键词：
D O I：
10.1038/nrd1494
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
A surprisingly large proportion of new drug candidates emerging from drug discovery programmes are water insoluble, and therefore poorly bioavailable, leading to abandoned development efforts. These so-called 'brickdust' candidates can now be rescued by formulating them into crystalline nanosuspensions. In the process of overcoming issues involving solubility, additional pharmacokinetic benefits of the drugs so formulated have come to be appreciated. As such, insolubility issues of the past have provoked a paradigm change, which now offers novel solutions for innovative drugs of the future.
引用
收藏
页码：785 / 796
页数：12
相关论文
共 50 条
  • [41] Temperature-Induced Surface Effects on Drug Nanosuspensions
    Simone Aleandri
    Monica Schönenberger
    Andres Niederquell
    Martin Kuentz
    Pharmaceutical Research, 2018, 35
  • [42] Cyclosporine A Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Cationic Nanoparticles and Drug-Core Mucus Penetrating Nanoparticles
    Yan, Rong
    Xu, Lai
    Wang, Quhe
    Wu, Zheng
    Zhang, Hua
    Gan, Li
    MOLECULAR PHARMACEUTICS, 2021, 18 (12) : 4290 - 4298
  • [43] Ocular tolerability of Eudragit RS100® and RL1009® nanosuspensions as carriers for ophthalmic controlled drug delivery
    Pignatello, R
    Bucolo, C
    Puglisi, G
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (12) : 2636 - 2641
  • [44] Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromene
    Pignatello, R
    Ricupero, N
    Bucolo, C
    Maugeri, F
    Maltese, A
    Puglisi, G
    AAPS PHARMSCITECH, 2006, 7 (01)
  • [45] Clay as a matrix former for spray drying of drug nanosuspensions
    Dong, Yuancai
    Ng, Wai Kiong
    Hu, Jun
    Shen, Shoucang
    Tan, Reginald B. H.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 465 (1-2) : 83 - 89
  • [46] Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery
    Liu, Yue
    Zhang, Dianrui
    Duan, Cunxian
    Jia, Lejiao
    Xie, Pengcheng
    Zheng, Dandan
    Wang, Feihu
    Liu, Guangpu
    Hao, Leilei
    Zhang, Xueshun
    Zhang, Qiang
    JOURNAL OF MICROENCAPSULATION, 2012, 29 (02) : 194 - 203
  • [47] In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery
    Wang, Yancai
    Zhang, Dianrui
    Liu, Zhaoping
    Liu, Guangpu
    Duan, Cunxian
    Jia, Lejiao
    Feng, Feifei
    Zhang, Xiaoyu
    Shi, Yanqiu
    Zhang, Qiang
    NANOTECHNOLOGY, 2010, 21 (15)
  • [48] Influence of drug physicochemical characteristics on in vitro transdermal absorption of hydrophobic drug nanosuspensions
    Shen, Cheng-ying
    Li, Rui-sheng
    Shen, Bao-de
    Shen, Gang
    Wang, Li-qiang
    Zheng, Juan
    Li, Xiao-rong
    Min, Hong-yan
    Han, Jin
    Yuan, Hai-long
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2015, 41 (12) : 1997 - 2005
  • [49] Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery
    Hao, Wenyan
    Cui, Yuexin
    Fan, Yueyue
    Chen, Mengyu
    Yang, Guobao
    Wang, Yuli
    Yang, Meiyan
    Li, Zhiping
    Gong, Wei
    Yang, Yang
    Gao, Chunsheng
    JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
  • [50] Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide
    Jacobs, C
    Kayser, O
    Müller, RH
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) : 161 - 164
12345